Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.740
+0.090 (5.45%)
At close: Jun 5, 2025, 4:00 PM
1.700
-0.040 (-2.30%)
After-hours: Jun 5, 2025, 7:36 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 33 employees as of December 31, 2024. The number of employees decreased by 14 or -29.79% compared to the previous year.
Employees
33
Change (1Y)
-14
Growth (1Y)
-29.79%
Revenue / Employee
n/a
Profits / Employee
-$1,573,515
Market Cap
115.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MIST News
- 8 days ago - Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 22 days ago - Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 2 months ago - Stock Picks From Seeking Alpha's March 2025 New Analysts - Seeking Alpha
- 2 months ago - Milestone Pharmaceuticals Shares Hit New Low After FDA Rejects Etripamil - Market Watch
- 2 months ago - US FDA declines to approve Milestone Pharma's heart rhythm nasal spray - Reuters
- 2 months ago - FDA Issues Complete Response Letter for Etripamil for PSVT - GlobeNewsWire
- 2 months ago - Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers - Seeking Alpha
- 2 months ago - Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology - GlobeNewsWire